In recent trading session, Angiodynamic Inc (NASDAQ:ANGO) saw 0.66 million shares changing hands at last check today with its beta currently measuring 0.63. Company’s recent per share price level of $11.99 trading at -$0.47 or -3.77% at last check today assigns it a market valuation of $485.18M. That most recent trading price of ANGO’s stock is at a discount of -12.59% from its 52-week high price of $13.50 and is indicating a premium of 56.13% from its 52-week low price of $5.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.77 million shares which gives us an average trading volume of 677.38K if we extend that period to 3-months.
For Angiodynamic Inc (ANGO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.13 in the current quarter.
Angiodynamic Inc (NASDAQ:ANGO) trade information
Upright in the red during last session for losing -3.77%, in the last five days ANGO remained trading in the red while hitting it’s week-highest on Thursday, 01/30/25 when the stock touched $11.99 price level, adding 11.19% to its value on the day. Angiodynamic Inc’s shares saw a change of 30.90% in year-to-date performance and have moved -1.64% in past 5-day. Angiodynamic Inc (NASDAQ:ANGO) showed a performance of 32.49% in past 30-days. Number of shares sold short was 1.0 million shares which calculate 1.8 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 13 to the stock, which implies a rise of 7.77% to its recent value today. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -0.08% in reaching the projected high whereas dropping to the targeted low would mean a loss of -0.08% for stock’s current value.
Angiodynamic Inc (ANGO) estimates and forecasts
Statistics highlight that Angiodynamic Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 52.93% of value to its shares in past 6 months, showing an annual growth rate of 2.63% while that of industry is 14.40. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to fall -6.25% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 70.3M for the same. And 3 analysts are in estimates of company making revenue of 74.23M in the next quarter. Company posted 65.97M and 70.98M of sales in current and next quarters respectively a year earlier.
Angiodynamic Inc (NASDAQ:ANGO)’s Major holders
Insiders are in possession of 5.60% of company’s total shares while institution are holding 81.30 percent of that, with stock having share float percentage of 86.13%. Investors also watch the number of corporate investors in a company very closely, which is 81.30% institutions for Angiodynamic Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at ANGO for having 4.6 million shares of worth $27.86 million. And as of 2024-06-30, it was holding 11.4443 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 2.19 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.4418 of outstanding shares, having a total worth of $13.25 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 1.2 shares of worth $14.34 million or 2.96% of the total outstanding shares. The later fund manager was in possession of 1.07 shares on Nov 30, 2024, making its stake of worth around $12.78 million in the company or a holder of 2.64% of company’s stock.
